SELE and neoplasm: Among the common symptoms of extramedullary infiltration, 83% of patients show skin lesions (3), possibly due to the binding between the highly expressed CLA/HECA-452 in tumor cells and E-selectin in dermal endothelial cells and cutaneous T cells (5).